Status:
NOT_YET_RECRUITING
RCT on the Treatment of Menopausal Syndrome With Chinese Medicine
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Menopause
Eligibility:
FEMALE
40-60 years
Phase:
PHASE2
Brief Summary
This is a double-blinded, randomized, placebo-controlled clinical trial. Subjects will be randomly assigned to the treatment group (Modified Guizhi Fuling granules) or placebo group (Placebo granules)...
Detailed Description
Menopausal syndrome is a series of symptoms caused by ovarian follicles degeneration that occurs before or after menopause. These symptoms include central nervous system-related disorders (such as hot...
Eligibility Criteria
Inclusion
- Female subjects with age between 40 and 60 years old;
- For those who have symptoms of primary menopause (irregular menstruation lasting for more than 6 months, or absence of menstrual periods for more than 3 months)
- The score of the physical symptoms in Greene Climacteric Symptom Score (GCS) is 6 or above (average level);
- Have moderate level (affecting certain level of daily activity) or severe (cannot carry out daily activity) hot flashes, defined as transient sensations of heat, sweating, flushing, anxiety and chills lasting for 1-5 minutes;
- Diagnosed Deficiency of Kidney essence and static blood in Lower Jiao by Chinese medicine practitioner
- Agreed to receive Chinese medication or placebo for 2 months upon randomization.
Exclusion
- The menopausal syndrome caused by surgical operations or medications (such as chemotherapy, gonadotropin-releasing hormone agonists, etc.).
- Have received estrogen treatment in the past 2 months;
- Have received any medication for treating menopause in the past month, including herbs, non-prescribed drugs, supplements, or change of diet to consume more legumes;
- Known serious emotional, mental or psychological disorders that may affect the study;
- During pregnancy, pre-pregnancy period, or lactation period;
- Known history of allergy to any traditional Chinese medicine;
- Have received anticoagulant or antiplatelet drugs in the past month;
- Known history of some certain serious medical disease, such as cardiovascular disease, liver or renal dysfunction, diabetes, cerebrovascular disease, blood disorders, with unstable conditions;
- Chinese medicine pattern combined with damp phlegm or damp heat, or only deficiency of Yin blood or absence of static blood pattern.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT06074809
Start Date
November 1 2023
End Date
January 31 2026
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Chinese Medicine
Shatin, Hong Kong